ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Irving L. Kron
Curtis G. Tribble
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Parrino, P. E.
Right arrow Articles by Tribble, C. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Parrino, P. E.
Right arrow Articles by Tribble, C. G.

Ann Thorac Surg 1999;67:59-64
© 1999 The Society of Thoracic Surgeons


Original Articles

Does a focal neurologic deficit contraindicate operation in a patient with endocarditis?

Patrick E. Parrino, MDa, Irving L. Kron, MDa, Scott D. Ross, MDa, Kimberly S. Shockey, MSa, Adam M. Krona, Michael A. Towler, MDa, Curtis G. Tribble, MDa

a Division of Thoracic and Cardiovascular Surgery, Department of Surgery, University of Virginia Health Sciences Center, Charlottesville, Virginia, USA

Address reprint requests to Dr Tribble, Department of Surgery, University of Virginia Health Sciences Center, Box 181-95, Charlottesville, VA 22908
e-mail: cgt2e{at}virginia.edu

Presented at the Poster Session of the Thirty-fourth Annual Meeting of The Society of Thoracic Surgeons, New Orleans, LA, Jan 26–28, 1998.

Background. As many as 40% of patients with left-sided bacterial endocarditis will sustain a neurologic insult. The importance of a neurologic change as an indication or a contraindication for valve replacement remains controversial.

Methods. We performed a retrospective analysis of the records of 33 patients admitted to the University of Virginia Health Sciences Center between January 1, 1978, and June 30, 1996, with a diagnosis of endocarditis and a neurologic change.

Results. All 33 patients had echocardiographic or pathologic evidence of left-sided endocarditis; 23 were seen with focal neurologic findings and had a mortality rate of 22% (5 of 23), and 10 patients were seen with nonfocal, diffuse encephalopathy and had a mortality rate of 60% (6 of 10) (p < 0.05). Of the 33 patients, 14 underwent operation and 19 were treated medically. The mortality rate was 21.4% (3 of 14) in the surgical group and 42.1% (8 of 19) in the medical group (p = not significant). In 71% (10 of 14) of the surgical patients, the operation was done within 1 week of the neurologic event. Additional neurologic deterioration occurred in 18.2% (2 of 11) of survivors in the surgical group and 9.1% (1 of 11) in the medical group (p = not significant).

Conclusions. Choosing therapy for a patient with endocarditis and a neurologic change remains a difficult challenge. Initial findings of nonfocal, global dysfunction on examination are a predictor of a poor outcome. By comparing surgical and medical groups derived from the same series of patients, it is clear that patients with bacterial endocarditis and central nervous system changes face substantial mortality regardless of intervention. However, these data demonstrate that when compared with a similar group of medical patients, surgical patients who require and receive operation early in the course of their illness do comparatively well. Improving outcomes by delaying surgical intervention may serve to "select out" hardier patients but will lead to the death of patients who might benefit from such intervention.




This article has been cited by other articles:


Home page
Eur Heart JHome page
Task Force Members, D. Horstkotte, F. Follath, E. Gutschik, M. Lengyel, A. Oto, A. Pavie, J. Soler-Soler, G. Thiene, A. von Graevenitz, et al.
Guidelines on Prevention, Diagnosis and Treatment of Infective Endocarditis Executive Summary: The Task Force on Infective Endocarditis of the European Society of Cardiology
Eur. Heart J., February 1, 2004; 25(3): 267 - 276.
[Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
C. Stollberger, J. Finsterer, A. Pratter, W. Kopsa, J. Preiser, and A. Valentin
Ischemic Stroke and Splenic Rupture in a Case of Streptococcus bovis Endocarditis
J. Clin. Microbiol., June 1, 2003; 41(6): 2654 - 2658.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
E. Mylonakis and S. B. Calderwood
Infective Endocarditis in Adults
N. Engl. J. Med., November 1, 2001; 345(18): 1318 - 1330.
[Full Text] [PDF]


Home page
Arch Intern MedHome page
M. Heiro, J. Nikoskelainen, E. Engblom, E. Kotilainen, R. Marttila, and P. Kotilainen
Neurologic Manifestations of Infective Endocarditis: A 17-Year Experience in a Teaching Hospital in Finland
Arch Intern Med, October 9, 2000; 160(18): 2781 - 2787.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1999 by The Society of Thoracic Surgeons.